1-3 of 3
Rie Imamura
Close
Sort by
Journal Articles

Once-Weekly Subcutaneous Bortezomib Plus Oral Cyclophosphamide and Dexamethasone Therapy For Relapsed Or Refractory Multiple Myeloma

Yasushi Takamatsu, MD, PhD, Yutaka Imamura, MD, Tomonori Nakazato, MD, Naokuni Uike, MD, PhD, Kaname Miyashita, MD, Yoshio Saburi, MD, PhD, Naoki Harada, MD, Shuichi Ota, MD, PhD, Rie Imamura, MD, Toshihiro Miyamoto, MD
Journal: Blood
Blood (2013) 122 (21): 5382.
https://doi.org/10.1182/blood.V122.21.5382.5382
Published: 2013
Journal Articles

Characterization of Circulating Monoclonal B Lymphocytes in Patients with HCV Infection

Korenori Ohtsubo, Takashi Okamura, Michio Sata, Takumi Kawaguchi, Satoshi Morishige, Yuka Takata, Eijiro Oku, Rie Imamura, Ritsuko Seki, Michitoshi Hashiguchi, Koichi Osaki, Kazuaki Yakushiji, Taisuke Kanaji, Kohji Yoshimoto, Takato Ueno
Journal: Blood
Blood (2008) 112 (11): 4911.
https://doi.org/10.1182/blood.V112.11.4911.4911
Published: 2008
Journal Articles

Target Dose Adjustment of Oral Busulfan Using a Test Dose in Japanese Adults Undergoing Hematopoietic Stem Cell Transplantation.

Yasushi Takamatsu, MD, Kentaro Ogata, PhD, Noriaki Sasaki, PhD, Shuuji Hara, PhD, Tetsuya Eto, MD, Kouji Kato, MD, Kouji Nagafuji, MD, Yasunobu Abe, MD, Akira Kubota, MD, Ilseung Choi, MD, Rie Imamura, MD, Yutaka Imamura, MD, Naoya Taira, MD, Junji Suzumiya, MD, Kazuo Tamura, MD
Journal: Blood
Blood (2005) 106 (11): 5313.
https://doi.org/10.1182/blood.V106.11.5313.5313
Published: 2005